PAPER Yun J, Nagai T, Furukawa-Hibi Y, Kuroda K, Kaibuchi K, Greenberg ME, Yamada K
SEARCH RESULTS
330988 RESULTS
PAPER Martin N, Bossenmeyer-Pourié C, Koziel V, Jazi R, Audonnet S, Vert P, Guéant JL, Daval JL, Pourié G
Non-injurious neonatal hypoxia confers resistance to brain senescence in aged male rats.
PLoS One. 2012;7(11):e48828. PubMed: 23173039PAPER Nicot S, Bencsik A, Morignat E, Mestre-Francés N, Perret-Liaudet A, Baron T
Differentiation of prions from L-type BSE versus sporadic Creutzfeldt-Jakob disease.
Emerg Infect Dis. 2012 Dec;18(12):2028-31. PubMed: 23171544PAPER Morales-Garcia JA, Luna-Medina R, Alonso-Gil S, Sanz-Sancristobal M, Palomo V, Gil C, Santos A, Martinez A, Perez-Castillo A
Glycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo.
ACS Chem Neurosci. 2012 Nov 21;3(11):963-71. PubMed: 23173075PAPER Gabathuler R
[New protein vectors for physiological transfer of therapeutic agents to the central nervous system].
Biol Aujourdhui. 2012;206(3):191-203. PubMed: 23171842PAPER Brännström K, Ohman A, Lindhagen-Persson M, Olofsson A
Ca2+ enhances Aβ polymerization rate and fibrillar stability in a dynamic manner.
Biochem J. 2013 Feb 15;450(1):189-97. PubMed: 23171033PAPER Lee DC, Rizer J, Hunt JB, Selenica ML, Gordon MN, Morgan D
Review: Experimental manipulations of microglia in mouse models of Alzheimer's pathology: activation reduces amyloid but hastens tau pathology.
Neuropathol Appl Neurobiol. 2013 Feb;39(1):69-85. PubMed: 23171029PAPER Jeffrey M
Membrane associated misfolded protein propagation in natural TSEs, synthetic prion diseases and Alzheimer's disease.
Neuropathol Appl Neurobiol. 2012 Nov 22; PubMed: 23171056PAPER Piazza-Gardner AK, Gaffud TJ, Barry AE
The impact of alcohol on Alzheimer's disease: A systematic review.
Aging Ment Health. 2013;17(2):133-46. PubMed: 23171229PAPER Liu Z, Chen HH, Li TL, Xu L, Du HQ
A cross-sectional study on cerebrospinal fluid biomarker levels in cognitively normal elderly subjects with or without a family history of Alzheimer's disease.
CNS Neurosci Ther. 2013 Jan;19(1):38-42. PubMed: 23171371PAPER Abner EL, Dennis BC, Mathews MJ, Mendiondo MS, Caban-Holt A, Kryscio RJ, Schmitt FA, , Crowley JJ
Practice effects in a longitudinal, multi-center Alzheimer's disease prevention clinical trial.
Trials. 2012;13:217. PubMed: 23171483PAPER McColl G, Roberts BR, Pukala TL, Kenche VB, Roberts CM, Link CD, Ryan TM, Masters CL, Barnham KJ, Bush AI, Cherny RA
Utility of an improved model of amyloid-beta (Aβ₁₋₄₂) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease.
Mol Neurodegener. 2012;7:57. PubMed: 23171715PAPER Andrieux K, Couvreur P
[Nanoparticles for brain delivery of drugs or contrast agents. Application to Alzheimer's disease].
Biol Aujourdhui. 2012;206(3):185-90. PubMed: 23171841PAPER Busch S, Wu L, Feng Y, Gretz N, Hoffmann S, Hammes HP
Alzheimer's disease and retinal neurodegeneration share a consistent stress response of the neurovascular unit.
Cell Physiol Biochem. 2012;30(6):1436-43. PubMed: 23171816PAPER Kim TK, Han HE, Kim H, Lee JE, Choi D, Park WJ, Han PL
Expression of the plant viral protease NIa in the brain of a mouse model of Alzheimer's disease mitigates Aβ pathology and improves cognitive function.
Exp Mol Med. 2012 Dec 31;44(12):740-8. PubMed: 23172351Current Filters
No filters selected